RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.
Chen Y, Mu Y, Guan Q, Li C, Zhang Y, Xu Y, Zhou C, Guo Y, Ma Y, Zhao M, Ji G, Liu P, Sun D, Sun H, Wu N, Jin Y.
Chen Y, et al. Among authors: guo y.
Cell Death Dis. 2023 Nov 20;14(11):757. doi: 10.1038/s41419-023-06156-6.
Cell Death Dis. 2023.
PMID: 37985768
Free PMC article.